Jessica Sanford

Jul 30, 2024 | meddeviceonline.com | Mark Witcher |André Ayres Martinez |DSM Biomedical |Jessica Sanford

Your company likely uses risk matrices and Failure Mode & Effects Analysis (FMEA) for analyzing risks. Let's explore an alternative approach for conducting a system failure mode & effects analysis. Membranes Allow For Greater Functionality In Oxygen-Dependent SensorsWearable biosensors have been widely adopted for diabetes management, with the potential for broader applications. Discover how polymer formulations are expanding the reach of this technology.

Jul 9, 2024 | meddeviceonline.com | Jayet Moon |Arun Mathew |Jessica Sanford |Jeff Phillips

Get the latest industry news and expert insights delivered straight to your inbox! Newsletter | July 9, 2024 The waterfall model and the V-model are commonly employed in medical device development. In our new era of the Quality Management System Regulation (QMSR), risk management can be integrated with the design control process. RFID For Med Devices: Identifying A PartnerRFID is increasingly being used in medical devices.

Jun 19, 2024 | meddeviceonline.com | Jessica Sanford

Get the latest industry news and expert insights delivered straight to your inbox! Article | June 19, 2024 By Jessica Sanford, Ph.D., Senior Human Factors Engineer, Battelle Explore the concept of wet injections, which occur when the injection device is removed from the skin while medication is still being delivered, resulting in underdosing.

Jun 4, 2024 | drugdeliveryleader.com | Jessica Sanford

By Jessica Sanford, Ph.D., Senior Human Factors Engineer The COVID-19 pandemic has significantly impacted education, resulting in a notable decline in literacy rates among children and adolescents. This decline is reflected in reading test scores and national assessments, raising concerns about long-term effects and disproportionate impacts on vulnerable groups.

Jun 4, 2024 | drugdeliveryleader.com | Jessica Sanford

By Jessica Sanford, Ph.D. Senior Human Factors Engineer, Battelle As the US population ages and the prevalence of cognitive decline increases, new research into cognitive and memory-related drug and combination device development is on the rise. This surge brings a heightened need for human factors testing that includes target users, potentially requiring study participants with cognitive impairments to determine if they can self-administer treatments.